Rationale and design of AVERROES: Apixaban versus...

Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

John W. Eikelboom, Martin O'Donnell, Salim Yusuf, Rafael Diaz, Greg Flaker, Robert Hart, Stefan Hohnloser, Campbell Joyner, Jack Lawrence, Prem Pais, Janice Pogue, David Synhorst, Stuart J. Connolly
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
159
Year:
2010
Language:
english
Pages:
3531
DOI:
10.1016/j.ahj.2009.08.026
File:
PDF, 208 KB
english, 2010
Conversion to is in progress
Conversion to is failed